A randomized Phase III trial of adjuvant S-1 therapy vs. observation alone in resected biliary tract cancer: Japan Clinical Oncology Group Study (JCOG1202, ASCOT)-Reference-Cited by-同舟云学术

A randomized Phase III trial of adjuvant S-1 therapy vs. observation alone in resected biliary tract cancer: Japan Clinical Oncology Group Study (JCOG1202, ASCOT)

Published:2018-02-15 Issue:4 Volume:48 Page:392-395
ISSN:1465-3621
Container-title:Japanese Journal of Clinical Oncology
language:en
Short-container-title:

Author:

Nakachi Kohei¹,Konishi Masaru²,Ikeda Masafumi³,Mizusawa Junki⁴,Eba Junko⁴,Okusaka Takuji⁵,Ishii Hiroshi⁶,Fukuda Haruhiko⁴,Furuse Junji⁷,

Affiliation:

1. Department of Gastroenterology, Otaru General Hospital, Otaru

2. Department of Hepatobiliary and Pancreatic Surgery, National Cancer Center Hospital East, Kashiwa

3. Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, Kashiwa

4. JCOG Data Center/Operations Office, National Cancer Center Hospital, Tokyo

5. Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo

6. Clinical Research Center, National Hospital Organization Shikoku Cancer Center, Matsuyama

7. Department of Medical Oncology, Kyorin University School of Medicine, Tokyo, Japan

Funder

National Cancer Center Research and Development

Practical Research for Innovative Cancer Control

Japan Agency for Medical Research and development

AMED

Ministry of Health, Labour and Welfare

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,General Medicine

Link

http://academic.oup.com/jjco/article-pdf/48/4/392/24523872/hyy004.pdf

Reference15 articles.

1. Epidemiology of biliary tract cancers: an update;Randi;Ann Oncol,2009

2. Biliary tract cancer registry in Japan from 2008 to 2013;Ishihara;J Hepatobiliary Pancreat Sci,2016

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research progress and prospect of postoperative adjuvant therapy for resectable intrahepatic cholangiocarcinoma;Frontiers in Pharmacology;2024-08-07

2. Targeting Isocitrate Dehydrogenase (IDH) in Solid Tumors: Current Evidence and Future Perspectives;Cancers;2024-08-02

3. Clinical Implications of the Degree of Pancreatic Invasion in Ampulla of Vater Carcinoma;Annals of Surgical Oncology;2024-08-02

4. The road to tailored adjuvant chemotherapy for all four non-pancreatic periampullary cancers: An international multimethod cohort study;British Journal of Cancer;2024-05-28

5. Surgical Resection Alone is Associated With Higher Long-Term Survival Than Multiagent Chemotherapy Alone for Patients With Localized Biliary Tract Cancers;Journal of Surgical Research;2024-03